Tocotrienol Dosage: How Much Do the Trials Actually Use?

By Erin Rose · Updated July 19, 2026 · Methodology

Educational summary — not medical advice. No government RDA, AI, or UL exists for tocotrienols specifically, and none of the doses below are established as treating or curing any condition. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

The dose depends on which outcome you're chasing

Tocotrienols don't have one settled dose the way an essential nutrient does — the trials in this evidence base used doses from 25 to 860 mg/day, and which number matters depends on which finding you're chasing. The dose-response cholesterol trial (Qureshi 2002, rice-bran TRF25) tested 25/50/100/200 mg/day over 35-day phases and found 100 mg/day produced the largest decreases in total cholesterol (20%), LDL-C (25%), ApoB (14%), and triglycerides (12%) — all significant. But read the authors' own caveat carefully: tocotrienols "are also converted to tocopherols in vivo, [so] it is necessary not to exceed a certain dose, as this would be counter-productive." That's a genuinely unusual dosing dynamic — more is not simply better, according to the trial that most directly tested the question. (Remember, too, that this same category of trial is the one with the weakest independent replication — see the full cholesterol-claim reckoning before treating 100 mg as a proven effective dose.)

The NAFLD trials used a considerably higher dose: Pervez 2020 and Pervez 2022 both dosed delta-tocotrienol at 300 mg twice daily (600 mg/day total) for 24 and 48 weeks respectively, and both found real improvements on their primary liver endpoints — though the head-to-head trial found that dose only equivalent to, not better than, standard alpha-tocopherol. See the full liver-evidence breakdown. The one human bone RCT (Shen 2018) tested two even higher doses — 430 mg/day and 860 mg/day annatto tocotrienol — in postmenopausal osteopenic women, and found no meaningful difference between the two doses on bone-resorption biomarkers, suggesting the lower 430 mg dose captured most of whatever effect exists.

How to think about timing and the tocopherol nuance

• 100–300 mg/day is the safest default reference point — it spans the dose-response "optimal" dose and most retail products, even though no dose here is a proven treatment for anything.
• Fat-soluble — take with a meal containing fat for absorption, same as tocopherol-form vitamin E.
• If a tocopherol-free product matters to you, check the label, not just the marketing. Annatto-derived products are naturally tocopherol-free; palm-derived full-spectrum products contain some native tocopherol alongside the tocotrienols.
• Higher isn't automatically better. The one trial that directly tested a dose-response found 100 mg/day optimal, with a plausible ceiling effect above it — a genuinely different dynamic from most supplements on this site.
• Delta- and gamma-tocotrienol isomers carry most of the human trial evidence (NAFLD, bone) in this pack; alpha- and beta-tocotrienol are less studied.
• Pregnant, breastfeeding, on anticoagulant medication, or with liver/kidney disease? Check with a clinician before use — several trials in this evidence base specifically studied medically supervised, compromised populations (hemodialysis, NAFLD), which is different from unsupervised self-use.

Frequently asked questions

Related

• Tocotrienols: what they are & the honest evidence
• Best Tocotrienols — ranked by sourcing disclosure, then cost
• Tocotrienols for Fatty Liver (NAFLD)
• Tocotrienols vs Tocopherols

Sources